News & Media
|Hemostemix Posts Corporate Presentation on Company Website|
|Jul 07 2015 -
Hemostemix Inc. ("Hemostemix" or the “Company”) (TSXV: HEM), a clinical-stage autologous cell-therapy company, announced today that it has posted a corporate presentation for investors and other interested parties on its website under the “Corporate & Investors” tab at hemostemix.com. The presentation provides an overview of the Company’s technology platform for treating critical limb ischemia and other reduced-blood-flow diseases, profiles of the industry-experienced management team, and details of the current clinical program, including timelines for product development.
For more information, please contact email@example.com